- Home
- MTG vs RVMD Comparison
MTG vs RVMD Comparison
Compare MTG & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTG
- RVMD
- Stock Information
- Founded
- MTG 1957
- RVMD 2014
- Country
- MTG United States
- RVMD United States
- Employees
- MTG N/A
- RVMD N/A
- Industry
- MTG Property-Casualty Insurers
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTG Finance
- RVMD Health Care
- Exchange
- MTG Nasdaq
- RVMD Nasdaq
- Market Cap
- MTG 6.4B
- RVMD 7.5B
- IPO Year
- MTG 1991
- RVMD 2020
- Fundamental
- Price
- MTG $28.52
- RVMD $37.87
- Analyst Decision
- MTG Hold
- RVMD Strong Buy
- Analyst Count
- MTG 8
- RVMD 12
- Target Price
- MTG $26.63
- RVMD $68.67
- AVG Volume (30 Days)
- MTG 2.3M
- RVMD 3.1M
- Earning Date
- MTG 07-30-2025
- RVMD 08-06-2025
- Dividend Yield
- MTG 1.82%
- RVMD N/A
- EPS Growth
- MTG 15.33
- RVMD N/A
- EPS
- MTG 3.00
- RVMD N/A
- Revenue
- MTG $1,219,604,000.00
- RVMD N/A
- Revenue This Year
- MTG $2.92
- RVMD N/A
- Revenue Next Year
- MTG $3.14
- RVMD $241.39
- P/E Ratio
- MTG $9.49
- RVMD N/A
- Revenue Growth
- MTG 4.64
- RVMD N/A
- 52 Week Low
- MTG $21.20
- RVMD $29.17
- 52 Week High
- MTG $28.67
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- MTG 67.39
- RVMD 44.16
- Support Level
- MTG $26.13
- RVMD $36.65
- Resistance Level
- MTG $28.35
- RVMD $38.18
- Average True Range (ATR)
- MTG 0.51
- RVMD 1.53
- MACD
- MTG 0.09
- RVMD -0.31
- Stochastic Oscillator
- MTG 94.09
- RVMD 29.10
About MTG MGIC Investment Corporation
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.